Skip to article
Astra

Hepatology

Spontaneous Bacterial Peritonitis

Diagnose SBP with prompt diagnostic paracentesis and ascitic neutrophil count, begin empiric therapy when PMNs reach 250/mm3, prevent renal deterioration with albumin when indicated, and actively exclude secondary peritonitis when the clinical or fluid profile is atypical.

Clinical question: How should clinicians diagnose, treat, reassess, and prevent spontaneous bacterial peritonitis in patients with cirrhotic ascites?

Initial decision

Who needs immediate diagnostic paracentesis?

Use paracentesis to establish infection rather than relying on symptoms or Gram stain.

Perform diagnostic paracentesis in a patient with cirrhosis and ascites when SBP is clinically suspected, including fever, abdominal pain or tenderness, or other evidence of infection. Diagnostic paracentesis is the basis of diagnosis, and ascites is associated with substantial SBP risk: prevalence is approximately 1.5% to 3.5% among outpatients and about 10% among hospitalized patients with cirrhosis. easl eu[PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC

Send ascitic fluid for cell count with differential and culture. Culture-negative neutrocytic ascites is managed as SBP when the PMN count is greater than 250/mm3. Gram stain is frequently negative and should not delay empiric treatment. ScienceDirectPeritoneum Exudate - an overview | ScienceDirect TopicsPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC

Obtain targeted ascitic studies when the presentation points away from uncomplicated SBP: add ascitic amylase for suspected pancreatic ascites, mycobacterial culture or PCR when tuberculosis is suspected, and cytology when malignancy is suspected. Ascitic glucose and lactate dehydrogenase help assess for secondary peritonitis. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractPubMedAscites - StatPearls - NCBI Bookshelf

Ascitic fluid findings that direct immediate management. PubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMCPubMedAscites - StatPearls - NCBI Bookshelf
FindingInterpretationImmediate action
PMNs >250/mm3SBP, including culture-negative neutrocytic ascites. PubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMCStart empiric antibacterial therapy without waiting for culture results. PubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC
PMNs <250/mm3 plus fever >37.8 degrees C, abdominal pain, or tendernessInfection remains clinically concerning while culture is pending. PubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMCBegin empiric antibiotics pending culture results. PubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC
Elevated ascitic amylase in an appropriate clinical settingSupports pancreatic ascites evaluation. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractPubMedAscites - StatPearls - NCBI BookshelfPursue pancreatic etiology rather than attributing fluid abnormalities to uncomplicated SBP. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractPubMedAscites - StatPearls - NCBI Bookshelf
Ascitic glucose and LDH pattern concerning for secondary peritonitisRaises concern for a nonspontaneous intra-abdominal source. PubMedAscites - StatPearls - NCBI BookshelfEscalate diagnostic evaluation for secondary peritonitis. easl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...PubMedAscites - StatPearls - NCBI Bookshelf

Acute treatment

Start empiric antibiotics once the PMN threshold is met

Select initial therapy by acquisition setting, local resistance patterns, and renal toxicity risk.

For presumed community-acquired SBP, a third-generation cephalosporin is a standard empiric option. Cefotaxime has guideline support and effective regimens include 2 g intravenously every 6 hours or every 12 hours; ceftriaxone 2 g intravenously every 24 hours is another reported regimen. Third-generation cephalosporins avoid the nephrotoxicity associated with aminoglycoside-containing empiric regimens. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsScienceDirectPeritoneum Exudate - an overview | ScienceDirect TopicsPubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - Abstract

Obtain ascitic fluid culture before antibiotics when this does not delay treatment, then narrow or modify therapy according to organism identification and susceptibility testing. Common implicated organisms include Escherichia coli, Klebsiella species, enterococci, and other gram-negative enteric flora; healthcare-associated and nosocomial SBP have greater multidrug-resistant and gram-positive pathogen concerns. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsWileyAntibiotic resistance in healthcare‐related and nosocomial ...PubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure

For healthcare-associated or nosocomial SBP, do not assume a community-acquired cephalosporin regimen will be adequate. EASL 2018 guidance emphasized adding gram-positive-active agents such as a glycopeptide, daptomycin, or linezolid in settings with high gram-positive infection prevalence; choose the regimen in conjunction with local antibiograms and the patient's prior antimicrobial exposure. PubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure

Empiric antibacterial options reported for SBP. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsScienceDirectPeritoneum Exudate - an overview | ScienceDirect TopicsPubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
Clinical contextRegimenDecision point
Presumed community-acquired SBPCefotaxime 2 g IV every 6 or 12 hours. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsBegin after diagnostic paracentesis when PMNs are >250/mm3; adjust to culture susceptibilities. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMC
Presumed community-acquired SBPCeftriaxone 2 g IV every 24 hours. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsAlternative third-generation cephalosporin regimen. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Presumed community-acquired SBPCeftazidime 2 g IV every 8 to 12 hours or amoxicillin-clavulanate 1 g/0.2 g IV every 8 hours. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsUse only when clinically appropriate; tailor once susceptibility data return. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Healthcare-associated or nosocomial SBP with high gram-positive prevalenceConsider adding a glycopeptide, daptomycin, or linezolid to empiric therapy. PubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failureBase selection on local resistance epidemiology and patient-specific resistance risk. PubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure

When to broaden beyond a standard cephalosporin regimen

Treat healthcare-associated and nosocomial SBP as a resistance-risk phenotype. Prior healthcare exposure, recent antimicrobials, or local high prevalence of multidrug-resistant organisms should trigger empiric regimen selection based on local microbiology rather than routine community-acquired coverage. WileyAntibiotic resistance in healthcare‐related and nosocomial ...PubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure

Renal protection

Use albumin to reduce hepatorenal complications

Treat SBP as a renal-risk event, not only an intra-abdominal infection.

Co-administer intravenous albumin with antibacterial therapy in SBP using 1.5 g/kg at diagnosis and 1 g/kg on day 3. In patients treated with cefotaxime, this strategy reduced the incidence of type 1 hepatorenal syndrome and mortality. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics

Follow renal function during acute infection because renal impairment after SBP has major prognostic implications and SBP is linked to hepatorenal syndrome. Worsening kidney function should prompt reassessment of infection control, circulatory status, and competing renal injury mechanisms rather than assuming uncomplicated SBP is resolving. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsPubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMCPubMedDiagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. - Abstract

Albumin regimen for SBP-associated renal-risk reduction. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
TimingAlbumin dosePurpose
At SBP diagnosis1.5 g/kg IV. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsReduces type 1 hepatorenal syndrome and mortality when used with cefotaxime. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics
Day 31 g/kg IV. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsCompletes the studied two-dose regimen. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topics

Diagnostic escalation

When should SBP be reconsidered as secondary peritonitis?

Failure of expected clinical improvement requires a search for a surgically or procedurally correctable source.

SBP requires infection of ascites without a contiguous intra-abdominal source such as bowel perforation or intra-abdominal abscess. If abdominal findings are disproportionate, the ascitic fluid profile is atypical, or the patient fails to improve on appropriate empiric therapy, evaluate for secondary bacterial peritonitis rather than simply extending the original regimen. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topicseasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...PubMedAscites - StatPearls - NCBI Bookshelf

Use ascitic glucose and lactate dehydrogenase as part of the secondary-peritonitis assessment, then direct imaging and source-control evaluation to the suspected pathology. Pancreatitis and tuberculosis should be pursued selectively with ascitic amylase and mycobacterial culture or PCR, respectively, rather than applying those tests routinely. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractPubMedAscites - StatPearls - NCBI Bookshelf

Do not equate ascitic culture negativity with treatment failure or diagnostic exclusion. A PMN count greater than 250/mm3 establishes SBP even if cultures are negative; the key reassessment question is whether the clinical course and fluid findings remain consistent with a spontaneous rather than secondary source. PubMedKASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMCGastroenterologyUtility of an Algorithm in Differentiating Spontaneous From ...

Alternative diagnoses to pursue when SBP is atypical or treatment response is inadequate. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect TopicsPubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - Abstracteasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...PubMedAscites - StatPearls - NCBI Bookshelf
Clinical concernTargeted testWhat the result changes
Secondary bacterial peritonitisAscitic glucose and LDH; evaluate for intra-abdominal source. PubMedAscites - StatPearls - NCBI BookshelfRedirects care toward imaging and source control rather than management as uncomplicated SBP. ScienceDirectSpontaneous Bacterial Peritonitis - an overview | ScienceDirect Topicseasl eu[PDF] EASL Clinical Practice Guidelines for the management of patients ...PubMedAscites - StatPearls - NCBI Bookshelf
Pancreatic ascitesAscitic amylase. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractPubMedAscites - StatPearls - NCBI BookshelfSupports pancreatic-source evaluation and management. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractPubMedAscites - StatPearls - NCBI Bookshelf
Tuberculous peritonitisAscitic mycobacterial culture or PCR. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractDirects organism-specific diagnosis and treatment. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - Abstract
Malignant ascitesAscitic cytology. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - AbstractDirects oncologic or malignancy-focused evaluation. PubMedThe clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - Abstract

Recurrence prevention

Who needs antibiotic prophylaxis after SBP or gastrointestinal bleeding?

Use prophylaxis in the highest-risk settings while accounting for resistance selection.

After recovery from SBP, prescribe long-term secondary prophylaxis with daily norfloxacin or trimethoprim-sulfamethoxazole. Norfloxacin and trimethoprim-sulfamethoxazole have similar efficacy for SBP prevention. WileyReview article: spontaneous bacterial peritonitis - Wiley Online LibraryPubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC

During gastrointestinal hemorrhage in a patient with cirrhosis, give antibacterial prophylaxis for 7 days. AASLD guidance cited intravenous ceftriaxone or oral norfloxacin; start with a parenteral antibiotic during active bleeding and transition to an oral agent when oral intake resumes, completing 7 days total. PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC

For primary prophylaxis in selected patients with cirrhosis and ascites, guideline appraisals describe long-term norfloxacin 400 mg daily in those with low ascitic fluid protein. Ciprofloxacin is an alternative to norfloxacin, but AASLD preference for daily rather than weekly ciprofloxacin reflects concern that weekly dosing may increase quinolone resistance. PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMCPubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure

Antibiotic prophylaxis settings in cirrhosis. PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMCPubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
IndicationRegimen describedDuration or operational rule
Previous SBPDaily norfloxacin or daily trimethoprim-sulfamethoxazole. PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMCLong-term secondary prophylaxis. PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC
Cirrhosis with gastrointestinal hemorrhageIV ceftriaxone or oral norfloxacin. PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMCTotal 7 days; begin parenteral therapy during active bleeding and switch to oral therapy when oral intake resumes. PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC
Selected primary prophylaxis candidates with low ascitic fluid proteinNorfloxacin 400 mg orally daily. PubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failureLong-term prophylaxis is described in appraised guidelines. PubMedEvaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
Alternative fluoroquinolone approachCiprofloxacin. PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMCDaily dosing is preferred over weekly dosing in AASLD-cited guidance because weekly administration may promote quinolone resistance. PubMedCiprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMC

References

  1. Spontaneous Bacterial Peritonitis - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  2. Peritoneum Exudate - an overview | ScienceDirect Topicswww.sciencedirect.com · www.sciencedirect.com
  3. Review article: spontaneous bacterial peritonitis - Wiley Online Libraryonlinelibrary.wiley.com · onlinelibrary.wiley.com
  4. Management of bacterial infections in cirrhosis - ScienceDirect.comwww.sciencedirect.com · www.sciencedirect.com
  5. Antibiotic resistance in healthcare‐related and nosocomial ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  6. Hepatorenal syndrome type 1 and bacterial infection: A catastrophic ...onlinelibrary.wiley.com · onlinelibrary.wiley.com
  7. Prevention and Management of Bacterial Infections in Cirrhosisonlinelibrary.wiley.com · onlinelibrary.wiley.com
  8. The impact of infection by multidrug- resistant agents in ... - Wileyaasldpubs.onlinelibrary.wiley.com · aasldpubs.onlinelibrary.wiley.com
  9. The clinical management of abdominal ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: a review of current guidelines and recommendations. - Abstractpubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
  10. [PDF] Hepatorenal-Cirrhosis-English-report.pdf - EASLeasl.eu · easl.eu
  11. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. - Abstractpubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
  12. Ciprofloxacin: Spontaneous Bacterial Peritonitis (Prevention) - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  13. Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failurepmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  14. [PDF] EASL Clinical Practice Guidelines for the management of patients ...easl.eu · easl.eu
  15. Management of Ascites, Spontaneous Bacterial Peritonitis ... - EASLeasl.eu · easl.eu
  16. Spontaneous Bacterial Peritonitis: We Are Still Behind - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  17. KASL clinical practice guidelines for liver cirrhosis: Ascites ... - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  18. Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome | Cleveland Clinic Journal of medicinewww.ccjm.org · www.ccjm.org
  19. Cirrhosis & Complications Archives - EASL-The Home of Hepatology.easl.eu · easl.eu
  20. Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. - Abstractpubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
  21. Chronic Liver Disease - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  22. Ascites - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  23. Editorials - Gastroenterologywww.gastrojournal.org · www.gastrojournal.org
  24. Utility of an Algorithm in Differentiating Spontaneous From ...www.gastrojournal.org · www.gastrojournal.org